Form 4: Macrogenics CFO James Karrels Sells 30,000 Shares

James Karrels, SVP, CFO and Secretary of Macrogenics Inc, sold 30,000 shares of common stock on March 4, 2024, at a price of $20.5 per share.

Summary

• On March 4, 2024, James Karrels, the SVP, CFO, and Secretary of Macrogenics Inc., sold 30,000 shares of the company's common stock.
• The sale was executed at a price of $20.5 per share.
• Following the transaction, Karrels directly owns 171,452 shares of Macrogenics Inc., jointly with his wife.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2022.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of an insider sale under a pre-existing trading plan.

Industry Context

This is a routine disclosure of an insider stock sale. Insider sales can sometimes be interpreted negatively by the market, but the existence of a pre-arranged 10b5-1 trading plan mitigates this concern as it indicates the sale was planned well in advance.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, although the pre-arranged trading plan mitigates this concern.

Key Dates